Stock Movers: BNP Paribas Falls, HSBC Gains, Novartis Down on Market News

BNP Paribas Faces Multiple Challenges

• 📉 BNP Paribas shares are down 2.6% due to its trading unit suffering a hit from souring debt in the third quarter.
• 🏦 Loan-loss provisions rose to €905 million, including €190 million for a specific credit situation in the global markets unit.
• ⚖️ The bank is also facing potential billions in settlements from a court ruling linking it to human rights abuses in Sudan two decades ago.
• 🇫🇷 Political instability in France and concerns about the French economy are also impacting the domestic business.
• ⚠️ BNP Paribas is currently the worst performer among large European banks.

HSBC Raises Profit Outlook Amid Mixed Results

• 📈 HSBC shares are up after the bank raised its profitability outlook for the year.
• 💰 This comes despite a decline in third-quarter profit, largely due to a $1.1 billion provision set aside for investor losses in the Madoff fraud case.
• 🔄 Investors are focusing on the raised outlook, overlooking mixed results, following a significant revamp under the CEO involving job cuts and a major bet on Hong Kong.
• ⚠️ Analysts note headwinds such as falling rates, muted loan growth, elevated impairments in commercial real estate, and ongoing litigation.

Novartis Stock Declines on Slowing Growth and Generic Competition

• 🔻 Novartis shares are down over 3% following third-quarter results that showed the slowest profit growth in almost two years.
• 🇺🇸 This slowdown is attributed to generic competition in the US, its key market, affecting sales of top-selling drugs like Entresto and Cosentyx.
• 💊 Novartis is pursuing new treatments through development and a $12 billion acquisition of Avidity Biosciences to mitigate this threat.
• 📉 The CEO expects the full impact of generic competition to hit in the fourth quarter, indicating further potential weakness.